What To Know
- He brings a wealth of expertise in the medical products space and will guide ThermoTek through its next phase of growth as it continues innovating and delivering post-orthopedic recovery solutions across the globe.
- Randy’s deep knowledge of the medical device industry, highly-regarded leadership and proven expertise in scaling businesses makes us confident he is the right executive to lead ThermoTek’s next chapter of growth,”.
April 14, 2021
Randy D. Chatman experience in key leadership roles for global industry bellwethers, include Wright Medical Group (acquired by Stryker), Covidien (acquired by Medtronic), Johnson & Johnson, and others.
“I’m honored to be named CEO of ThermoTek,” said Chatman. “Thermotek is in a unique position to launch new product lines, grow into adjacent medical and industrial markets and acquire complementary private companies.”
Before joining ThermoTek, Chatman served as the Vice President of Strategic Contracting, Pricing, National Accounts, Reimbursement & Market Access for Wright Medical Group, a global medical device company focused on extremities and biologics which recently sold to Stryker for $4.7 billion. He brings a wealth of expertise in the medical products space and will guide ThermoTek through its next phase of growth as it continues innovating and delivering post-orthopedic recovery solutions across the globe.
“We are thrilled to have Randy join the ThermoTek team. Randy’s deep knowledge of the medical device industry, highly-regarded leadership and proven expertise in scaling businesses makes us confident he is the right executive to lead ThermoTek’s next chapter of growth,” commented Christopher W. Kersey, M.D., M.B.A., Founding Managing Partner of Havencrest Capital Management.
